Health
Celiac Drug That Targets the Immune System Shows Promise
2021-04-08
Download
Right click and do "save link as"
A new study that approaches treating celiac disease by using nanoparticles to program the immune system to tolerate gluten showed promise in early results.
The study concluded that the drug, TAK-101, prevented gluten from triggering an immune reaction in those who have celiac disease. The results were published in the journal Gastroenterology.
Full Study here: https://www.gastrojournal.org/article/S0016-5085(21)00521-7/pdf?referrer=https%3A%2F%2Fwww.gastrojournal.org%2F
Hosted on Acast. See acast.com/privacy for more information.
More Episodes
Fall News and Notes
2023-10-18
2023-10-18
Still Having Symptoms? It May Be FODMAPS
2023-10-17
2023-10-17
Do Digestive Enzymes WorK?
2023-10-16
2023-10-16
Allergen Free Halloween Candy Pt 2
2023-10-13
2023-10-13
The Impact of Celiac on Kids' Mental Health
2023-10-11
2023-10-11
Allergen Free Halloween Candy Ideas Pt. 1
2023-10-10
2023-10-10
Allergen Free Candy Ideas Pt. 1
2023-10-10
2023-10-10
The Gluten Free Diet Helps Fibromyalgia
2023-10-09
2023-10-09
Award Winning Pizza Crust Mix
2023-10-05
2023-10-05
Why the Celiac Cruise is Extra Special
2023-10-04
2023-10-04
New Research Supporting Teens with Celiac
2023-10-03
2023-10-03
Boston Gluten Free Expo
2023-09-25
2023-09-25
Italy Will Begin Testing All Kids for Celiac
2023-09-19
2023-09-19
Do You Deal with Brain Fog?
2023-09-18
2023-09-18
New Gluten Free Trader Joe's Products
2023-09-11
2023-09-11
Get this podcast on your
phone, FREE
